Intravascular ultrasound assessment of postprocedural incomplete stent apposition

Journal of Invasive Cardiology

Volumn 24, Issue 1, 2012, Pages 13-16

  Kume, Teruyoshi ^a   Waseda, Katsuhisa ^a   Ako, Junya ^a   Sakata, Kenji ^a   Yamasaki, Masao ^a   Shimohama, Takao ^a   Tsujino, Ichizo ^a   Hasegawa, Takao ^a   Fitzgerald, Peter J ^a   Honda, Yasuhiro ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

apposition; balloon sizing; intravascular ultrasound; ISA

Indexed keywords

EVEROLIMUS; PACLITAXEL; DRUG DERIVATIVE; RAPAMYCIN;

ADULT; AGED; ANGIOGRAPHY; ARTICLE; BALLOON CATHETER; CALCIFICATION; DRUG ELUTING STENT; FEMALE; HUMAN; IMAGE QUALITY; INTRAVASCULAR ULTRASOUND; MAJOR CLINICAL STUDY; MALE; RISK FACTOR; VOLUMETRY; CALCINOSIS; CORONARY ARTERY DISEASE; CORONARY BLOOD VESSEL; ECHOGRAPHY; ENDOSCOPIC ECHOGRAPHY; INCIDENCE; MIDDLE AGED; RANDOMIZED CONTROLLED TRIAL (TOPIC); RETROSPECTIVE STUDY; TRANSLUMINAL CORONARY ANGIOPLASTY;

AGED; ANGIOPLASTY, BALLOON, CORONARY; CALCINOSIS; CORONARY ARTERY DISEASE; CORONARY VESSELS; DRUG-ELUTING STENTS; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PACLITAXEL; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RETROSPECTIVE STUDIES; SIROLIMUS; ULTRASONOGRAPHY, INTERVENTIONAL;

EID: 84858429897     PISSN: 10423931     EISSN: 15572501     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Ako J, Morino Y, Honda Y, et al. Late incomplete stent apposition after sirolimuseluting stent implantation: A serial intravascular ultrasound analysis. J Am Coll Cardiol. 2005;46(6):1002-1005. (Pubitemid 41316506)
2. Steinberg DH, Mintz GS, Mandinov L, et al. Long-term impact of routinely detected early and late incomplete stent apposition: An integrated intravascular ultrasound analysis of the TAXUS IV, V, and VI and TAXUS ATLAS workhorse, long lesion, and direct stent studies. JACC Cardiovasc Interv. 2010;3(5):486-494.
3. Kimura M, Mintz GS, Carlier S, et al. Outcome after acute incomplete sirolimus-eluting stent apposition as assessed by serial intravascular ultrasound. Am J Cardiol. 2006;98(4):436-442. (Pubitemid 44162867)
4. Fujii K, Carlier SG, Mintz GS, et al. Stent underexpansion and residual reference segment stenosis are related to stent thrombosis after sirolimus-eluting stent implantation: An intravascular ultrasound study. J Am Coll Cardiol. 2005;45(7):995-998. (Pubitemid 40432428)
5. Degertekin M, Serruys PW, Tanabe K, et al. Long-term follow-up of incomplete stent apposition in patients who received sirolimus-eluting stent for de novo coronary lesions: An intravascular ultrasound analysis. Circulation. 2003;108(22):2747-2750. (Pubitemid 37498975)
6. Tanabe K, Serruys PW, Degertekin M, et al. Incomplete stent apposition after implantation of paclitaxel-eluting stents or bare metal stents: Insights from the randomized TAXUS II trial. Circulation. 2005;111(7):900-905. (Pubitemid 40279892)
7. Hong MK, Mintz GS, Lee CW, et al. Incidence, mechanism, predictors, and long-term prognosis of late stent malapposition after bare-metal stent implantation. Circulation. 2004;109(7):881-886. (Pubitemid 38252740)
8. Uren NG, Schwarzacher SP, Metz JA, et al. Predictors and outcomes of stent thrombosis: An intravascular ultrasound registry. Eur Heart J. 2002;23(2):124-132. (Pubitemid 35204230)
9. Gonzalo N, Barlis P, Serruys PW, et al. Incomplete stent apposition and delayed tissue coverage are more frequent in drug-eluting stents implanted during primary percutaneous coronary intervention for ST-segment elevation myocardial infarction than in drug-eluting stents implanted for stable/unstable angina: Insights from optical coherence tomography. JACC Cardiovasc Interv. 2009;2(5):445-452.
10. Tanigawa J, Barlis P, Dimopoulos K, Dalby M, Moore P, Di Mario C. The influence of strut thickness and cell design on immediate apposition of drug-eluting stents assessed by optical coherence tomography. Int J Cardiol. 2009;134(2):180-188.
11. Kim YS, Koo BK, Seo JB, et al. The incidence and predictors of postprocedural incomplete stent apposition after angiographically successful drug-eluting stent implantation. Catheter Cardiovasc Interv. 2009;74(1):58-63.
12. Mosseri M, Satler LF, Pichard AD, Waksman R. Impact of vessel calcification on outcomes after coronary stenting. Cardiovasc Revasc Med. 2005;6(4):147-153. (Pubitemid 41739636)
13. Gerber R, Colombo A. Does IVUS guidance of coronary interventions affect outcome? A prime example of the failure of randomized clinical trials. Catheter Cardiovasc Interv. 2008;71(5):646-654. (Pubitemid 351550404)
14. Chevalier B, Di Mario C, Neumann FJ, et al. A randomized, controlled, multicenter trial to evaluate the safety and efficacy of zotarolimus- versus paclitaxel-eluting stents in de novo occlusive lesions in coronary arteries. The ZoMaxx I trial. JACC Cardiovasc Interv. 2008;1(5):524-532.
15. Gray WA, Yeung AC, Cutlip DE, et al. A randomized, controlled, multi-center trial comparing the safety and efficacy of zotarolimus-eluting and paclitaxel-eluting stents in de novo lesions in coronary arteries: final results of the ZoMaxx II trial. Int J Cardiol. 2011 Jun 7. (Epub ahead of print).
16. Waseda K, Hasegawa T, Ako J, et al. Comparison of vascular response to zotarolimus-eluting stent vs paclitaxel-eluting stent implantation: pooled IVUS results from the ZoMaxx I and II trials. Circ J. 2010;74(11):2334-2339.
17. Stone GW, Midei M, Newman W, et al. Comparison of an everolimus-eluting stent and a paclitaxel-eluting stent in patients with coronary artery disease: A randomized trial. JAMA. 2008;299(16):1903-1913. (Pubitemid 351574920)
18. Shimohama T, Ako J, Yamasaki M, et al. SPIRIT III JAPAN versus SPIRIT III USA: A comparative intravascular ultrasound analysis of the everolimus-eluting stent. Am J Cardiol. 2010;106(1):13-17.
19. Miyazawa A, Ako J, Hongo Y, et al. Comparison of vascular response to zotarolimus-eluting stent versus sirolimus-eluting stent: Intravascular ultrasound results from ENDEAVOR III. Am Heart J. 2008;155(1):108-113. (Pubitemid 350234763)
20. Sakurai R, Hongo Y, Yamasaki M, et al. Detailed intravascular ultrasound analysis of Zotarolimus- eluting phosphorylcholine-coated cobalt-chromium alloy stent in de novo coronary lesions (results from the ENDEAVOR II trial). Am J Cardiol. 2007;100(5):818-823.
21. Waseda K, Miyazawa A, Ako J, et al. Intravascular ultrasound results from the ENDEAVOR IV trial: Randomized comparison between zotarolimus- and paclitaxel-eluting stents in patients with coronary artery disease. JACC Cardiovasc Interv. 2009;2(8):779-784.
22. Ozaki Y, Okumura M, Ismail TF, et al. The fate of incomplete stent apposition with drugeluting stents: An optical coherence tomography-based natural history study. Eur Heart J. 2010;31(12):1470-1476.
23. Moses JW, Leon MB, Popma JJ, et al. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med. 2003;349(14):1315-1323. (Pubitemid 37186209)
24. Iakovou I, Schmidt T, Bonizzoni E, et al. Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA. 2005;293(17):2126-2130. (Pubitemid 40617065)
25. Stone GW, Ellis SG, Cox DA, et al. A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease. N Engl J Med. 2004;350(3):221-231.(Pubitemid 38067635)